1-247451538-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004492.2(OR2B11):āc.445G>Cā(p.Val149Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004492.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2B11 | NM_001004492.2 | c.445G>C | p.Val149Leu | missense_variant | 2/2 | ENST00000641149.2 | NP_001004492.1 | |
OR2B11 | NR_169840.1 | n.1099G>C | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2B11 | ENST00000641149.2 | c.445G>C | p.Val149Leu | missense_variant | 2/2 | NM_001004492.2 | ENSP00000492892 | P1 | ||
OR2B11 | ENST00000641527.1 | c.445G>C | p.Val149Leu | missense_variant | 3/3 | ENSP00000493421 | P1 | |||
OR2B11 | ENST00000641613.1 | n.1099G>C | non_coding_transcript_exon_variant | 5/5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251270Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135818
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461832Hom.: 0 Cov.: 72 AF XY: 0.00000550 AC XY: 4AN XY: 727224
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.445G>C (p.V149L) alteration is located in exon 1 (coding exon 1) of the OR2B11 gene. This alteration results from a G to C substitution at nucleotide position 445, causing the valine (V) at amino acid position 149 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at